Literature DB >> 8018387

Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man.

S Oka1, S Ida, T Shioda, Y Takebe, N Kobayashi, Y Shibuya, K Ohyama, K Momota, S Kimura, K Shimada.   

Abstract

We encountered a case of HIV-1 infection in a previously healthy man, which was characterized by rapid progression to AIDS and death within 7 months in association with high levels of antigenemia throughout the clinical course and no humoral immune response for at least 6 months. Genetic changes of the third variable domain (V3) of the envelope gene of HIV-1 in serum samples were analyzed at four time points during his rapid clinical course. The nucleotide changes were confined to a maximum of three substitutions among 105 nucleotides of the V3 region. A major population of the viral clones in this patient showed one amino acid substitution from aspartic acid (a negatively charged amino acid) to lysine (a positively charged amino acid) at position 30 from the first cysteine of the V3 loop. This substitution was thought to be associated with phenotypic changes, and viruses with this sequence in the V3 region had a strong syncytium-inducing ability in MT-4 cells. It appears that the lack of a humoral immune response accelerated disease progression in our patient and a genetic change that appeared to produce a phenotypic change occurred at an early stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018387     DOI: 10.1089/aid.1994.10.271

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.

Authors:  Y Koyanagi; Y Tanaka; J Kira; M Ito; K Hioki; N Misawa; Y Kawano; K Yamasaki; R Tanaka; Y Suzuki; Y Ueyama; E Terada; T Tanaka; M Miyasaka; T Kobayashi; Y Kumazawa; N Yamamoto
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression.

Authors:  T Shioda; S Oka; X Xin; H Liu; R Harukuni; A Kurotani; M Fukushima; M K Hasan; T Shiino; Y Takebe; A Iwamoto; Y Nagai
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.

Authors:  A Radaelli; G Kraus; A Schmidt; P Badel; J McClure; S L Hu; W Morton; C De Giuli Morghen; F Wong-Staal; D Looney
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Authors:  J M Binley; P J Klasse; Y Cao; I Jones; M Markowitz; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  The rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains.

Authors:  T Kuwata; Y Miyazaki; T Igarashi; J Takehisa; M Hayami
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.

Authors:  T Shioda; S Oka; S Ida; K Nokihara; H Toriyoshi; S Mori; Y Takebe; S Kimura; K Shimada; Y Nagai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.

Authors:  N Strunnikova; S C Ray; R A Livingston; E Rubalcaba; R P Viscidi
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.

Authors:  Ke Zhuang; Andres Finzi; Silvana Tasca; Madina Shakirzyanova; Heather Knight; Susan Westmoreland; Joseph Sodroski; Cecilia Cheng-Mayer
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.